RESEARCH-USE BIOSIMILAR ANTIBODY
Encelimab
Monoclonal antibody · IgG4
Encelimab is an anti-LAG3 antibody. Encelimab blocks the interaction between LAG-3 and MHC II, and enhances T-cell activation. Encelimab alone or in combination with an anti-PD-1 antibody reduces tumor size in a lymphoma mice model (A20 cell xenograft).
TARGETLAG3
YMonoclonal antibody
CATALOGSC-BS-583
CATALOG NUMBERSC-BS-583
MOLECULAR WEIGHTApprox. 144.58 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Encelimab is an anti-LAG3 antibody. Encelimab blocks the interaction between LAG-3 and MHC II, and enhances T-cell activation. Encelimab alone or in combination with an anti-PD-1 antibody reduces tumor size in a lymphoma mice model (A20 cell xenograft).
Encelimab is a recombinant research-use antibody directed against LAG3.